Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry

Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry

Background Dupilumab has been approved to treat moderate-to-severe atopic dermatitis; however, the data in a real-world setting are still limited. Objective To analyze the effectiveness and safety of dupilumab. Methods This was a real-life Czech multicenter retrospective study from patients treated...

Full description

Bibliographic Details
Main Authors: Martina Kojanova, Milena Tanczosova, Daniela Strosova, Petra Cetkovska, Jorga Fialova, Tomas Dolezal, Alena Machovcova, Spyridon Gkalpakiotis, on behalf of the BIOREP Study Group
Format: Article
Language:English
Published: Taylor & Francis Group 2022-07-01
Series:Journal of Dermatological Treatment
Subjects:
atopic dermatitis
biological therapy
dupilumab
real-world
registries
biorep
Online Access:http://dx.doi.org/10.1080/09546634.2022.2043545

Internet

http://dx.doi.org/10.1080/09546634.2022.2043545

Similar Items